About this document

Deterioro Cognitivo Vascular y Demencia 2026 by edna.velah is a document available to read on EtoBox.

Vascular Cognitive Impairment and Dementia (VCID) is the second most common form of dementia, with no FDA-approved therapies currently available. This review discusses existing treatments, such as donepezil and nutraceuticals, and emphasizes the importance of prevention through managing hypertension and hyperglycemia. Future research should focus on novel technologies and treatment strategies to improve outcomes for VCID patients.

Author

edna.velah

Language

EN